TickerFacts.

CNBX Pharmaceuticals Inc. (CNBX): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-08-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

553.96M
As of 2025-08-31
1.48B
As of 2026-05-31
n/m
3-year compound annual growth
2013-08-31: 1.36M2014-08-31: 100.25M2015-08-31: 101.50M2016-08-31: 107.22M2017-08-31: 119.54M2018-08-31: 121.58M2019-08-31: 134.50M2020-08-31: 135.08M2021-08-31: 148.66M2022-08-31: 1.24M2023-08-31: 22.61M2024-08-31: 31.11M2025-08-31: 553.96M553.96M
2013-08-31 Shares Outstanding (shares) 2025-08-31
Period endedShares OutstandingChange YoYSource filing
2025-08-31553.96Mn/m2025-12-01, Balance as of period end
2024-08-3131.11M+37.6%2025-12-01, Balance as of period end
2023-08-3122.61Mn/m2024-11-29, Balance as of period end
2022-08-311.24Mn/c2023-11-30, Balance as of period end
2021-08-31148.66M+10.1%2022-11-30, Balance as of period end
2020-08-31135.08M+0.4%2021-11-29, Balance as of period end
2019-08-31134.50M+10.6%2020-11-04, Balance as of period end
2018-08-31121.58M+1.7%2019-11-29, Balance as of period end
2017-08-31119.54M+11.5%2018-11-29, Balance as of period end
2016-08-31107.22M+5.6%2017-12-08, Balance as of period end
2015-08-31101.50M+1.3%2016-12-13, Balance as of period end
2014-08-31100.25Mn/m2016-01-07, Balance as of period end
2013-08-311.36Mn/a2015-10-23, Balance as of period end